Average 2022 Medicare Advantage premium to decrease, enrollment to increase: CMS
(By Nick Moran for Becker’s Hospital Review) The average premium for 2022 Medicare Advantage plans will be down to $19 per
Read More
Part D/Prescription Drugs
Repurposing drugs can speed new treatments for Covid-19
(By Robert Goldberg for STAT) As the summer of 2021 started to unfold, many Americans thought the pandemic was beginning to
Read MoreAlzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining
Read MoreStrategies for lowering your health care costs in retirement
According to the experts at Fidelity, you will need about $300,000 to cover your health care costs, that’s even with
Read MoreWho Qualifies for a Covid Booster? The List Is Growing Longer
On Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of
Read MoreRemdesivir reduces Covid hospitalizations when given early, study shows
(By Matthew Herper for STAT) Gilead’s Covid-19 drug remdesivir appeared to reduce hospitalizations by 87% in high-risk patients diagnosed early
Read More6 drugmakers referred to HHS inspector general for denying 340B discounts
(By Maia Anderson for Becker’s Hospital Review) The HHS Health Resources & Services Administration sent letters to six drugmakers Sept.
Read MoreThe brain health paradox: Dementia rates have fallen even as drugs have failed
(By Daniel R. George and Peter Whitehouse for STAT) Billions of dollars have been spent in pursuit of a pharmaceutical
Read MoreLess than 5% of US population accounts for 50% of healthcare spending: study
(By Alia Paavola for Becker’s Hospital Review) Less than 5 percent of the U.S. population accounted for half of healthcare
Read MoreThe FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID
(By Scott Hensley for NPR) The Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine
Read More